Biotech | May 03, 2021
Biosimilars performance below expectations for Biocon : ICICI Direct
The progress has been encouraging with approvals and launches in the US, EU, Japan, Australia and Emerging Markets. Post Mylan Upjohn (Pfizer) merger, the scope has been extended to China as well.
